The negative pressure wound therapy devices market size is expected to grow from US$ 2.03 billion in 2022 to US$ 3.15 billion by 2030.

Factors such as an increase in the prevalence of diabetic foot ulcers, pressure ulcers, etc., are likely to propel the continuous growth of the negative pressure wound therapy devices market.

Increase in Use of Negative Pressure Wound Therapy Devices Drives Market Growth

The use of negative pressure wound therapy (NPWT) as a surgical, chronic, and acute wound treatment option is growing. It is also used to specialize in managing open abdominal wounds (laparotomies) that expose the stomach and other intraperitoneal organs. The length of hospital in-patient stays is decreasing, leading to a rise in the use of NPWT in community settings. Community nurses are now managing many patients who would have otherwise been admitted to an acute setting with complex or highly exuding wounds. This, in turn, augments the use of negative pressure wound therapy device products, thereby driving the market's growth. For instance, according to PressQIPP, Every year, over US$ 3.36 million (?3.1 million) is spent in England and Wales on prescription supplies used in negative pressure wound therapy (NPWT).

Market Trend

Technological Advancement in Negative Pressure Wound Therapy Devices

The negative pressure wound therapy devices market trends include technological advancement. The integration of smart technologies for real-time monitoring of wound conditions, which allows healthcare professionals to track healing progress remotely, the development of more compact and wearable NPWT devices, which offer increased mobility for patients and may improve adherence to treatment plans, and the use of novel materials in dressing components to improve the efficacy of NPWT and encourage better wound healing are examples of technological advancements in NPWT devices. NPWT with instillation is one of the newest innovations in negative pressure. This leaves the foam dressing in place and combines irrigation and lavage of the wound with subsequent fluid removal by negative pressure at automated, timed repetitive intervals. Cutting-edge technology combines the VAC Ulta (KCI) NPWT system with VAC VeraFlo Therapy (KCI) to maintain minimum negative pressure between fluid instillation periods.

Negative Pressure Wound Therapy Devices Market, by Product:

Based on the product, the negative pressure wound therapy devices market analysis is carried out by considering the following segments: reusable NPWT devices and single-use NPWT devices. The reusable NPWT device segment held the largest market share in 2022. Reusable devices have advantages such as cost-effectiveness, patient safety, etc., which leads to an increase in the use of reusable NPWT devices and thereby drives the growth of the segment

Negative Pressure Wound Therapy Devices Market, by Wound Type:

By wound type, the market is segmented as a diabetic foot ulcer, pressure ulcer, venous leg ulcers, and others. The pressure ulcer segment held the largest negative pressure wound therapy devices market share in 2022. Enhance overall patient care outcomes by raising awareness at all levels, from the general public to healthcare professionals, likely drives the segment's growth.

Competitive Landscape and Key Companies:

3M, Smith+Nephew, DeRoyal Industries, Inc., Nexa Medical Limited, Lion Street Medical, LLC (Pensar Medical LLC), ConvaTec Inc., Cardinal Health, Inc., Mölnlycke Health Care AB, PAUL HARTMANN, and Medela AG are the prominent companies in the negative pressure wound therapy devices market report. These companies focus on new technologies, upgrading existing products, and geographic expansions to meet the growing consumer demand worldwide.